Hereditary Angioedema: Management Updates for the Specialty Pharmacist

Specialty Pharmacy Times, June 2020, Volume 3, Issue 2

This continuing education activity is supported by an educational grant from Takeda.

THIS ACTIVITY IS SUPPORTED BY AN EDUCATIONAL GRANT FROM TAKEDA.

FACULTY

Melanie B. Radi, PharmD, CSP

Manager, Clinical Programs Specialty Clinical Services

AllianceRx Walgreens Prime

Pittsburgh, Pennsylvania

At the completion of this activity, the participant will be able to:

  • Characterize the diagnosis and background of hereditary angioedema (HAE) and the significance of early intervention
  • Examine the clinical data of FDA-approved agents and emerging therapies for acute treatment and prophylaxis of HAE
  • Explore the need for individualized treatment and the role of the specialty pharmacist in patient education for effective HAE management

TARGET AUDIENCE: Pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: May 15, 2020

EXPIRATION DATE: May 15, 2021

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.